title: Intravitreal injection of triamcinolone acetonide for macular edema due to retinitis pigmentosa and other retinal diseases.
authors.affiliation: Moran Eye Center, Department of Ophthalmology and Visual Science, University of Utah, Salt Lake City, UT, USA.
authors.forename: Changguang
authors.initials: C
authors.lastname: Wang
authors.forename: Jianbin
authors.initials: J
authors.lastname: Hu
authors.forename: Paul S
authors.initials: PS
authors.lastname: Bernstein
authors.forename: Michael P
authors.initials: MP
authors.lastname: Teske
authors.forename: Marielle
authors.initials: M
authors.lastname: Payne
authors.forename: Zhenglin
authors.initials: Z
authors.lastname: Yang
authors.forename: Chumei
authors.initials: C
authors.lastname: Li
authors.forename: David
authors.initials: D
authors.lastname: Adams
authors.forename: Jennifer H
authors.initials: JH
authors.lastname: Baird
authors.forename: Kang
authors.initials: K
authors.lastname: Zhang
mesh_terms: D000305:Adrenal Cortex Hormones / Q000494:pharmacology; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007267:Injections; D008269:Macular Edema / Q000188:drug therapy*; D012164:Retinal Diseases / Q000188:drug therapy*; D012174:Retinitis Pigmentosa / Q000150:complications* / Q000188:drug therapy*; D012189:Retrospective Studies; D013997:Time Factors; D016896:Treatment Outcome; D014222:Triamcinolone Acetonide / Q000008:administration & dosage*; D014822:Vitreous Body / Q000187:drug effects*
chemical_list: D000305:Adrenal Cortex Hormones; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D014222:Triamcinolone Acetonide